Easy bruising resident survival guide: Difference between revisions
No edit summary |
|||
(21 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
<div style="width: 1px; height: 1px; background-color: #999999; position: fixed; top: 10px; left: 10px"></div> | |||
<div style="width: 90%; -webkit-user-select: none;"> | |||
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 5%; background: #A8A8A8; position: fixed; top: 250px; right: 20px; border-radius: 10px 10px 10px 10px;" cellpadding="0" cellspacing="0"; | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #A8A8A8;" align=center| {{fontcolor|#2B3B44|Easy bruising resident survival guide}} | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Overview|Overview]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Causes|Causes]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Diagnosis|Diagnosis]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Overview|Diagnostic clues]] | |||
|- | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Treatment|Treatment]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Do's|Do's]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[Easy bruising resident survival guide#Don'ts|Don'ts]] | |||
|} | |||
__NOTOC__ | |||
{{CMG}} {{AE}} {{NS}} | {{CMG}} {{AE}} {{NS}} | ||
{{SK}} | |||
== Overview == | == Overview == | ||
Easy bruising is the bruising of skin with minor compression or pressure. When small [[capillaries]] of the superficial skin rupture from pressure or compression, [[petechiae]] occur, sometimes [[ecchymosis]] is also seen with insignificant trauma which is a bleed in the deeper layers in the [[skin]] | Easy bruising is the bruising of skin with minor compression or pressure. When small [[capillaries]] of the superficial skin rupture from pressure or compression, [[petechiae]] occur, sometimes [[ecchymosis]] is also seen with insignificant trauma which is a bleed in the deeper layers in the [[skin]]. A wide variety of causes lead to easy bruising, some of which are [[coagulopathy|clotting]] and [[bleeding disorder]]s, [[platelet]] dysfunction, age-related skin changes, and some forms of cancer such as [[leukemia]]. | ||
== Causes == | == Causes == | ||
Line 29: | Line 52: | ||
== Diagnosis == | == Diagnosis == | ||
The algorithm below summarises approach to the different causes of easy bruising.<ref name=" | The algorithm below summarises approach to the different causes of easy bruising.<ref name="pmid7794090">{{cite journal| author=Srámek A, Eikenboom JC, Briët E, Vandenbroucke JP, Rosendaal FR| title=Usefulness of patient interview in bleeding disorders. | journal=Arch Intern Med | year= 1995 | volume= 155 | issue= 13 | pages= 1409-15 | pmid=7794090 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7794090 }} </ref><ref name="pmid7432180">{{cite journal| author=Wahlberg T, Blombäck M, Hall P, Axelsson G| title=Application of indicators, predictors and diagnostic indices in coagulation disorders. I. Evaluation of a self-administered questionnaire with binary questions. | journal=Methods Inf Med | year= 1980 | volume= 19 | issue= 4 | pages= 194-200 | pmid=7432180 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7432180 }} </ref><ref name="MauerKhazanov2011">{{cite journal|last1=Mauer|first1=A. C.|last2=Khazanov|first2=N. A.|last3=Levenkova|first3=N.|last4=Tian|first4=S.|last5=Barbour|first5=E. M.|last6=Khalida|first6=C.|last7=Tobin|first7=J. N.|last8=Coller|first8=B. S.|title=Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults|journal=Journal of Thrombosis and Haemostasis|volume=9|issue=1|year=2011|pages=100–108|issn=15387933|doi=10.1111/j.1538-7836.2010.04105.x}}</ref> | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | A01 | |A01=<div style="float: left; text-align: left; line-height: 150% ">'''Detailed history:'''<br> | {{familytree | | | | | | | | | | | | | | | | | | | | | | A01 | |A01=<div style="float: left; text-align: left; line-height: 150% ">'''Detailed history:'''<br> | ||
Line 62: | Line 86: | ||
== Diagnostic clues == | == Diagnostic clues == | ||
Shown below is a table summarizing different findings in easy bruising and their interpretation. | Shown below is a table summarizing different findings in easy bruising and their interpretation.<ref name="pmid1279101">{{cite journal| author=Schuurman R, Jacobs M, van Strien A, van der Noordaa J, Sol C| title=Analysis of splice sites in the early region of bovine polyomavirus: evidence for a unique pattern of large T mRNA splicing. | journal=J Gen Virol | year= 1992 | volume= 73 ( Pt 11) | issue= | pages= 2879-86 | pmid=1279101 | doi=10.1099/0022-1317-73-11-2879 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1279101 }} </ref> | ||
{| Class="wikitable" | {| Class="wikitable" | ||
! | ! Associated conditions | ||
! | ! Platelet count | ||
! | ! Bleeding time | ||
! | ! RIPA | ||
! | ! Peripheral smear | ||
! | ! PT | ||
! | ! aPTT | ||
! | ! Fibrinogen | ||
! Thrombin time | |||
! Factor assays | ! Factor assays | ||
|- | |- | ||
| [[Thrombocytopenia]] | |||
| ↓ | | ↓ | ||
| ↑ | | ↑ | ||
Line 84: | Line 109: | ||
| Normal | | Normal | ||
| Normal | | Normal | ||
|- | |- | ||
| [[Von Willebrand disease]] | |||
| Normal | | Normal | ||
| ↑ | | ↑ | ||
Line 95: | Line 120: | ||
| Normal | | Normal | ||
| ↓ [[Factor VIII]] | | ↓ [[Factor VIII]] | ||
|- | |- | ||
| [[Bernard-Soulier syndrome]] | |||
| ↓ | | ↓ | ||
| ↑ | | ↑ | ||
Line 106: | Line 131: | ||
| Normal | | Normal | ||
| Normal | | Normal | ||
|- | |- | ||
|[[Glanzmann's thrombasthenia]] | |||
| Normal | | Normal | ||
| ↑ | | ↑ | ||
Line 117: | Line 142: | ||
| Normal | | Normal | ||
| Normal | | Normal | ||
|- | |- | ||
| [[Hemophilia A overview|Hemophilia A]], [[Hemophilia B overview|Hemophilia B]], use of [[Heparin]], [[Antiphospholipid syndrome]] or [[Lupus anticoagulant]] | |||
| Normal | | Normal | ||
| Normal | | Normal | ||
Line 128: | Line 153: | ||
| Normal | | Normal | ||
| ↓ [[Factor VIII]], IX, XI or XII | | ↓ [[Factor VIII]], IX, XI or XII | ||
|- | |- | ||
| [[Factor VII]] deficiency, early in the course of treatment with [[warfarin]], initial stages of liver disease | |||
| Normal | | Normal | ||
| Normal | | Normal | ||
Line 139: | Line 164: | ||
| Normal | | Normal | ||
| ↓ [[Factor VII]] | | ↓ [[Factor VII]] | ||
|- | |- | ||
| Factor II, V or X deficiency, [[oral anticoagulant]] use, [[Vitamin K]] deficiency, chronic liver disease | |||
| Normal | | Normal | ||
| Normal | | Normal | ||
Line 150: | Line 175: | ||
| Normal | | Normal | ||
| ↓ Factor II, V & X | | ↓ Factor II, V & X | ||
|- | |- | ||
| Chronic liver disease, [[hyperfibrinolysis]], [[heparin]] use | |||
| Normal | | Normal | ||
| Normal | | Normal | ||
Line 161: | Line 186: | ||
| ↑ | | ↑ | ||
| Normal | | Normal | ||
|- | |- | ||
| | |[[Splenomegaly]], [[chemotherapy]], immune mediated destruction | ||
| ↓ | | ↓ | ||
| Normal | | Normal | ||
Line 172: | Line 196: | ||
| Normal | | Normal | ||
| Normal | | Normal | ||
| | | Normal/↓ | ||
|- | |- | ||
| Multiple [[transfusion]]s, massive blood loss | |||
| ↓ | | ↓ | ||
| ↑ | | ↑ | ||
Line 183: | Line 208: | ||
| ↑ | | ↑ | ||
| Normal | | Normal | ||
|- | |- | ||
| [[Disseminated intravascular coagulation]] | |||
| ↓ | | ↓ | ||
| ↑ | | ↑ | ||
Line 194: | Line 219: | ||
| ↑ | | ↑ | ||
| Normal/↓ | | Normal/↓ | ||
|} | |} | ||
== | == Treatment == | ||
The goal of treatment of [[easy bruising]] is to identify and treat the underlying disorder. | The goal of treatment of [[easy bruising]] is to identify and treat the underlying disorder. <ref name="ValenteAbramson2006">{{cite journal|last1=Valente|first1=Maria J.|last2=Abramson|first2=Neil|title=Easy Bruisability|journal=Southern Medical Journal|volume=99|issue=4|year=2006|pages=366–370|issn=0038-4348|doi=10.1097/01.smj.0000209237.73616.33}}</ref> | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | | | A01 |A01='''Categorize the bruises and other symptoms'''}} | {{familytree | | | | | | | | | | | | | | | A01 |A01='''Categorize the bruises and other symptoms'''}} | ||
Line 207: | Line 231: | ||
{{familytree | | | | | | | | | | | C01 | | | | | | | C02 |C01=<div style="float: left; text-align: left; line-height: 150% ">❑ Rest <br>❑ Ice <br>❑ Elevation <br>❑ Compression <br>❑ [[NSAIDs]] for pain|C02=<div style="float: left; text-align: left; line-height: 150% ">'''Initial investigations''' <br> [[Complete blood count]] with [[platelet]] count <br>❑ [[PT]]/[[aPTT]] <br>❑ [[INR]] <br>❑ [[Liver function tests]] <br>❑ [[Thyroid function tests]] <br>❑ [[Renal function tests]] <br>❑ [[Peripheral smear]] <br>❑ [[Bleeding time]] <br>❑ [[Platelet function analyzer]]</div>}} | {{familytree | | | | | | | | | | | C01 | | | | | | | C02 |C01=<div style="float: left; text-align: left; line-height: 150% ">❑ Rest <br>❑ Ice <br>❑ Elevation <br>❑ Compression <br>❑ [[NSAIDs]] for pain|C02=<div style="float: left; text-align: left; line-height: 150% ">'''Initial investigations''' <br> [[Complete blood count]] with [[platelet]] count <br>❑ [[PT]]/[[aPTT]] <br>❑ [[INR]] <br>❑ [[Liver function tests]] <br>❑ [[Thyroid function tests]] <br>❑ [[Renal function tests]] <br>❑ [[Peripheral smear]] <br>❑ [[Bleeding time]] <br>❑ [[Platelet function analyzer]]</div>}} | ||
{{familytree | | | | | | | | | | | |,|-|-|-|-|v|-|-|-|+|-|-|-|.|}} | {{familytree | | | | | | | | | | | |,|-|-|-|-|v|-|-|-|+|-|-|-|.|}} | ||
{{familytree | | | | | | | | | | | D01 | | | |!| | | D02 | | | | {{familytree | | | | | | | | | | | D01 | | | |!| | | D02 | | |!|D01='''Thrombocytopenia''' <br> [[Platelet]] transfusion after ruling out other conditions|D02='''Disorders of platelet function'''}} | ||
{{familytree | | | | | | | | | | | | | | | | |!| | | |!| | | |!|}} | |||
{{familytree | | | | | | | | | | | | | | | | |!| | | E01 | | |!|E01=<div style="float: left; text-align: left; line-height: 150% ">'''[[von Willebrand disease]]''' <br>❑ [[Desmopressin]] releases [[weibel-palade bodies]] from [[endothelial cell]]s <br>❑ [[von Willebrand factor]] concentrate <br>❑ [[Tranexamic acid]] <br>❑ [[Estrogen]] containing [[oral contraceptive pill]]s for women who are affected <br>❑ Human-derived medium purity [[Factor VIII]] concentrate <br> '''[[Glanzmann's thrombasthenia]]''' <br>❑ Avoid [[aspirin]] and [[NSAID]]s <br>❑ [[Tranexamic acid]] or [[Aminocaproic acid]] <br>❑ [[Oral contraceptive pills]] to decrease menstrual bleeding <br>❑ Recombinant Factor VIIa <br> '''[[Bernard-Soulier syndrome]]''' <br>❑ [[Platelet]] transfusion <br>❑ [[Tranexamic acid]] <br>❑ Avoid [[aspirin]] <br> | |||
---- | |||
'''Acquired disorders of platelet function''' <br> '''Uremic platelet dysfunction''' <br>❑ [[Erythropoietin]] can be used for prevention and treatment <br>❑ [[Cryoprecipitate]] can be used in bleeding diathesis <br>❑ [[Desmopressin]] is the agent used most commonly in active bleeding <br>❑ [[Estrogen]] acts by decreasing L-Arginine which in turn decreases Nitric Oxide which sees an increased production in uremia <br> '''Drugs such as [[aspirin]]''' <br>❑ Discontinuation of drug <br>❑ [[DDAVP]] for mild bleeding <br>❑ [[Platelet]] transfusion for major bleeding <br> '''[[Cardiopulmonary bypass]]''' <br>❑ [[Heparin]] <br>❑ Serine protease inhibitors such as [[aprotinin]] <br> ❑ Decreasing platelet adhesiveness with [[Nitric oxide]] <br>❑ [[Dypyridamole]] <br> '''Antiplatelet antibodies''' <br>❑ [[Corticosteroids]] <br>❑ [[Rituximab]] <br>❑ [[Splenectomy]] <br>❑ [[Intravenous immunoglobulin]]</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | F01 | | | | | | |!|F01= '''Disorders of secondary hemostasis'''}} | |||
{{familytree | | | | | | | | |,|-|-|-|v|-|-|-|+|-|-|-|.| | | |!|}} | |||
{{familytree | | | | | | | | G01 | | G02 | | G03 | | | G04 | |!|G01=<div style="float: left; text-align: left; line-height: 150% ">'''[[Hemophilia A overview|Hemophilia A]]''' <br>❑ Recombinant [[Factor VIII]] <br>❑ [[Plasma]] transfusions <br>❑ [[Desmopressin]] for mild bleeds|G02=<div style="float: left; text-align: left; line-height: 150% ">'''[[Hemophilia B overview|Hemophilia B]]'''<br>❑ [[Factor IX]] infusion <br>❑ [[Blood]] or [[plasma]] transfusions in severe bleeding <br>❑ Avoid [[NSAID]]s <br>❑ [[Tranexamic acid]] should be given before any procedure|G03=<div style="float: left; text-align: left; line-height: 150% ">'''[[Hemophilia C]]'''<br>❑ [[Fresh frozen plasma]] <br>❑ Recombinant [[Factor XI]] <br>❑ Cyclokapron is used as a preventative measure and treatment|G04=<div style="float: left; text-align: left; line-height: 150% ">'''Disorders of [[fibrinogen]]'''<br>❑ [[Afibrinogenemia]] and [[hypofibrinogenemia]]- plasma derived [[fibrinogen]] concentrate</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!|}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | H01 |H01='''No abnormalities detected on initial screen'''}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!|}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | I01 |I01='''Consider other diagnosis'''}} | |||
{{familytree | | | | | | | |,|-|-|-|-|v|-|-|-|v|-|-|-|v|-|-|-|+|-|.|}} | |||
{{familytree | | | | | | | J01 | | | J02 | | J03 | | J04 | | J05 |!|J01='''Senile purpura''' <br>❑ Topical [[retinoids]] may be of some benefit|J02=<div style="float: left; text-align: left; line-height: 150% ">'''Infections''' <br>❑ '''[[Dengue fever]]''' <br>* [[Oral rehydration therapy]] <br>* [[Blood]] transfusion in severe cases <br>❑ '''Meningococcal infection''' <br>* Third generation [[cephalosporin]]s <br>* Hydration|J03='''Aplastic anemia''' <br>❑ [[Bone marrow transplant]] <br>❑ [[Antithymocyte globulin]] <br>❑ [[Chemotherapy]] in some cases|J04=<div style="float: left; text-align: left; line-height: 150% ">'''[[Thrombotic thrombocytopenic purpura|TTP]]''' <br>❑ Transfusion is '''contraindicated''' <br>❑ [[Plasmapheresis]] <br>❑ [[Fresh frozen plasma]] <br>❑ [[Cryoprecipitate]] <br>❑ [[Corticosteroids]] <br>❑ [[Rituximab]] <br>❑ [[Caplacizumab]] <br>❑ [[Splenectomy]] <br>❑ Immunosupressive agents <br>'''[[Idiopathic thrombocytopenic purpura|ITP]] <br>❑ [[Corticosteroids]] <br>❑ [[Splenectomy]] <br>❑ [[Intravenous immunoglobulin]] <br>❑ [[Romiplostim]] or [[Etrombopag]] <br> '''[[Hemolytic-uremic syndrome|HUS]] <br>❑ [[Hemodialysis]] <br>❑ [[Corticosteroids]] <br>❑ [[Plasmapheresis]]| J05=<div style="float: left; text-align: left; line-height: 150% ">'''[[Vitamin]] deficiencies''' <br>❑ '''[[Scurvy]]''' <br>* [[Vitamin C]] supplementation <br>❑ '''[[Vitamin K]] deficiency''' <br>* [[Phytonadione injection|Phytonadione]] <br>* [[Vitamin K]] by IV infusion for bleeding</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |!|}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | K01 |K01=<div style="float: left; text-align: left; line-height: 150% ">❑'''[[Lupus anticoagulant]]'''<br>* [[LMWH]] <br>* [[Warfairn]] <br>❑ '''[[Antiphospholipid syndrome]]'''<br>* [[Aspirin]](preferred in pregnancy)<br>*[[Warfarin]] <br>* [[LMWH]] <br>❑ [[Ehlers-Danlos syndrome]] <br>* There is no known cure <br>* [[Physiotherapy]] and [[Occupational therapy]] <br> [[Vitamin C]] may help with bruising <br>❑ '''[[Leukemia]]'''<br>* [[Chemotherapy]] <br>❑ '''[[Plasminogen activator inhibitor-1]] deficiency'''<br>* [[Tranexamic acid]] <br>* [[Aminocaproic acid]] <br>❑ '''[[Alpha-2 antiplasmin]] deficiency'''<br>* [[Tranexamic acid]] <br>* [[Aminocaproic acid]] <br>❑ '''[[Factor XIII]] deficiency'''<br>* [[Factor XIII]] concentrate <br>❑ '''Liver disease'''<br>* [[Eltrombopag]] <br>* [[Romiplostim]] <br>* [[Platelet]] transfusions if necessary <br>❑ '''Domestic abuse''' must be considered in any patient with multiple bruises after ruling out other pathologies</div>}} | |||
{{familytree/end}} | |||
== Do's == | == Do's == | ||
* Order a [[peripheral smear]] for all patients to rule out presence of shistocytes in conditions like [[TTP]]/[[HUS]], [[DIC]] which need emergency treatment. | |||
* Educate patients about red flag signs signs wherever appropriate such as [[epistaxis]], [[hematemesis]], [[melena]], [[lethargy]], pale and clammy [[hands]] and [[feet]], [[oliguria]] or [[anuria]]. | |||
* Early [[vaccination]] in all patients with hemophilia. | |||
* Educate patients with bleeding disorders about wearing a [[medical identification tag]] in case of trauma or if emergency surgery is needed. | |||
* Consider [[Vitamin C]] and [[Vitamin K]] supplementation. | |||
* Appropriate measures to increase factor levels or [[platelets]] before any dental procedures or surgeries such as factor infusion, [[cryoprecipitate]], [[fresh frozen plasma]], [[platelet]] or [[blood]] transfusions. | |||
* Regular follow up with factor levels, [[platelet]] count and response to therapy. | |||
* [[Hepatitis C]], [[Hepatitis B]] and [[HIV]] screening in patients who have received blood transfusions in the past. | |||
== Dont's == | == Dont's == | ||
* Avoid contact sports. | |||
* Avoid repeated pricks for investigations/ blood sample collection in patients with hemophilia or other bleeding disorders. | |||
* Transfusion is contraindicated in [[TTP]]. | |||
* Do not prescribe [[aspirin]] or other [[NSAIDs]] during phases of active bleeding. | |||
== References == | == References == | ||
{{Reflist|2}} | |||
<references /> | |||
[[Category:Up-To-Date]] |
Latest revision as of 15:57, 17 December 2020
Easy bruising resident survival guide |
---|
Overview |
Causes |
Diagnosis |
Diagnostic clues |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sanjana Nethagani, M.B.B.S.[2]
Synonyms and keywords:
Overview
Easy bruising is the bruising of skin with minor compression or pressure. When small capillaries of the superficial skin rupture from pressure or compression, petechiae occur, sometimes ecchymosis is also seen with insignificant trauma which is a bleed in the deeper layers in the skin. A wide variety of causes lead to easy bruising, some of which are clotting and bleeding disorders, platelet dysfunction, age-related skin changes, and some forms of cancer such as leukemia.
Causes
Life threatening causes
- Thrombotic Thrombocytopenic Purpura
- Disseminated intravascular coagulation
- Leukemia
- Severe thrombocytopenia
Other causes
- Hemophilia A
- Hemophilia B
- Scurvy
- Von Willebrand disease
- Ehlers-Danlos syndrome
- Corticosteroid use
- Anticoagulant therapy
- Idiopathic Thrombocytopenic Purpura
- Henoch-Schonlein Purpura
- Vitamin K deficiency
- Liver disease
- Systemic Lupus Erythematosus
- Glanzmann Thrombasthenia
- Bernard-Soulier syndrome
For a full list of causes of easy bruising, click here.
Diagnosis
The algorithm below summarises approach to the different causes of easy bruising.[1][2][3]
Detailed history: ❑ Is the bleeding over the limbs? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characterize the symptoms ❑ Bruising with minor or no trauma ❑ Petechiae ❑ Gingival bleeding ❑ Menorrhagia ❑ Painful bleeding into joints | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial investigations ❑ Complete blood count with platelet count ❑ PT/aPTT ❑ INR ❑ Liver function tests ❑ Thyroid function tests ❑ Renal function tests ❑ Peripheral smear ❑ Bleeding time ❑ Platelet function analyzer Other investigations ❑ Factor VIII level ❑ Factor IX level ❑ Fibrinogen level ❑ ADAMTS13 level | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disorders of secondary hemostasis ❑ Abnormal PT/aPTT ❑ Abnormal factor assays ❑ Abnormal fibrinogen level | Decreased platelet count ❑ mild: 100,000 - 150,000 per µL ❑ moderate: 50,000 to 99,000 per µL ❑ severe: <50,000 per µL (may require transfusion) | Disorders of platelet function ❑ Prolonged bleeding time ❑ Thrombocytopenia ❑ Abnormal PFA-100 ❑ Abnormal Von Willebrand factor assay ❑ Abnormal Ristocetin induced platelet agglutination | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clotting factor disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inherited | Acquired | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Von Willebrand disease * Abnormal Von Willebrand factor assay * Abnormal Glycoprotein 1b assay * Hypoactive agglutination on ristocetin induced platelet aggregation * Low factor VIII levels * Prolonged PTT ❑ Glanzmann's thrombasthenia * Abnormal platelet aggregation assays * Monoclonal antibody testing * Flow cytometry ❑ Bernard-Soulier syndrome * Giant platelets on peripheral smear * Abnormal ristocetin aggregation ❑ Oculocutaneous albinism/Hermansky-Pudlak syndrome * Absent dense bodies on electron microscopy of platelets * Abnormal platelet aggregation assays ❑ Chédiak-Higashi syndrome * Abnormal platelet aggregation assays * Defective platelet storage granules ❑ Isolated dense granule deficiency * Defective platelet aggregation * Decreased ADP/ATP ratio | ❑ Uremia ❑ Acquired Von Willebrand disease ❑ Aspirin and other NSAIDs ❑ Glycoprotein IIb/IIIa inhibitors ❑ Cardiopulmonary bypass ❑ Dysproteinemia ❑ Myeloproliferative disorders ❑ Cardiopulmonary bypass ❑ Infections such as Dengue fever or Hepatitis C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No abnormalities detected in initial analysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Consider other diagnoses ❑ Senile purpura ❑ Aplastic anemia ❑ Long term corticosteroid use ❑ Scurvy ❑ Vitamin K deficiency ❑ Domestic abuse ❑ Leukemia ❑ Meningococcal infection ❑ Ehlers-Danlos syndrome ❑ Alpha 2-antiplasmin deficiency ❑ Plasminogen activator inhibitor-1 deficiency ❑ Factor XIII deficiency ❑ Lupus anticoagulant ❑ Antiphospholipid syndrome ❑ ITP ❑ TTP/HUS ❑ Liver disease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic clues
Shown below is a table summarizing different findings in easy bruising and their interpretation.[4]
Associated conditions | Platelet count | Bleeding time | RIPA | Peripheral smear | PT | aPTT | Fibrinogen | Thrombin time | Factor assays |
---|---|---|---|---|---|---|---|---|---|
Thrombocytopenia | ↓ | ↑ | Normal | Few platelets on smear | Normal | Normal | Normal | Normal | Normal |
Von Willebrand disease | Normal | ↑ | Hypoactive agglutination | Normal | Normal | Normal/ slightly prolonged | Normal | Normal | ↓ Factor VIII |
Bernard-Soulier syndrome | ↓ | ↑ | Hypoactive agglutination & normal ristocetin cofactor assay | Giant platelets | Normal | Normal | Normal | Normal | Normal |
Glanzmann's thrombasthenia | Normal | ↑ | Clumping with ristocetin | Normal | Normal | Normal | Normal | Normal | Normal |
Hemophilia A, Hemophilia B, use of Heparin, Antiphospholipid syndrome or Lupus anticoagulant | Normal | Normal | Normal | Normal | Normal | ↑ | Normal | Normal | ↓ Factor VIII, IX, XI or XII |
Factor VII deficiency, early in the course of treatment with warfarin, initial stages of liver disease | Normal | Normal | Normal | Normal | ↑ | Normal | Normal | Normal | ↓ Factor VII |
Factor II, V or X deficiency, oral anticoagulant use, Vitamin K deficiency, chronic liver disease | Normal | Normal | Normal | Normal | ↑ | ↑ | Normal | Normal | ↓ Factor II, V & X |
Chronic liver disease, hyperfibrinolysis, heparin use | Normal | Normal | Normal | Normal | ↑ | ↑ | Normal | ↑ | Normal |
Splenomegaly, chemotherapy, immune mediated destruction | ↓ | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal/↓ |
Multiple transfusions, massive blood loss | ↓ | ↑ | Normal | Normal | ↑ | ↑ | ↓ | ↑ | Normal |
Disseminated intravascular coagulation | ↓ | ↑ | Normal | Shistocytes | ↑ | ↑ | ↓ | ↑ | Normal/↓ |
Treatment
The goal of treatment of easy bruising is to identify and treat the underlying disorder. [5]
Categorize the bruises and other symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild bruises | Moderate to severe bruises and other accompanying symptoms | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial investigations Complete blood count with platelet count ❑ PT/aPTT ❑ INR ❑ Liver function tests ❑ Thyroid function tests ❑ Renal function tests ❑ Peripheral smear ❑ Bleeding time ❑ Platelet function analyzer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thrombocytopenia Platelet transfusion after ruling out other conditions | Disorders of platelet function | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
von Willebrand disease ❑ Desmopressin releases weibel-palade bodies from endothelial cells ❑ von Willebrand factor concentrate ❑ Tranexamic acid ❑ Estrogen containing oral contraceptive pills for women who are affected ❑ Human-derived medium purity Factor VIII concentrate Glanzmann's thrombasthenia ❑ Avoid aspirin and NSAIDs ❑ Tranexamic acid or Aminocaproic acid ❑ Oral contraceptive pills to decrease menstrual bleeding ❑ Recombinant Factor VIIa Bernard-Soulier syndrome ❑ Platelet transfusion ❑ Tranexamic acid ❑ Avoid aspirin Acquired disorders of platelet function Uremic platelet dysfunction ❑ Erythropoietin can be used for prevention and treatment ❑ Cryoprecipitate can be used in bleeding diathesis ❑ Desmopressin is the agent used most commonly in active bleeding ❑ Estrogen acts by decreasing L-Arginine which in turn decreases Nitric Oxide which sees an increased production in uremia Drugs such as aspirin ❑ Discontinuation of drug ❑ DDAVP for mild bleeding ❑ Platelet transfusion for major bleeding Cardiopulmonary bypass ❑ Heparin ❑ Serine protease inhibitors such as aprotinin ❑ Decreasing platelet adhesiveness with Nitric oxide ❑ Dypyridamole Antiplatelet antibodies ❑ Corticosteroids ❑ Rituximab ❑ Splenectomy ❑ Intravenous immunoglobulin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disorders of secondary hemostasis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemophilia B ❑ Factor IX infusion ❑ Blood or plasma transfusions in severe bleeding ❑ Avoid NSAIDs ❑ Tranexamic acid should be given before any procedure | Hemophilia C ❑ Fresh frozen plasma ❑ Recombinant Factor XI ❑ Cyclokapron is used as a preventative measure and treatment | Disorders of fibrinogen ❑ Afibrinogenemia and hypofibrinogenemia- plasma derived fibrinogen concentrate | |||||||||||||||||||||||||||||||||||||||||||||||||||||
No abnormalities detected on initial screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider other diagnosis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Senile purpura ❑ Topical retinoids may be of some benefit | Infections ❑ Dengue fever * Oral rehydration therapy * Blood transfusion in severe cases ❑ Meningococcal infection * Third generation cephalosporins * Hydration | Aplastic anemia ❑ Bone marrow transplant ❑ Antithymocyte globulin ❑ Chemotherapy in some cases | TTP ❑ Transfusion is contraindicated ❑ Plasmapheresis ❑ Fresh frozen plasma ❑ Cryoprecipitate ❑ Corticosteroids ❑ Rituximab ❑ Caplacizumab ❑ Splenectomy ❑ Immunosupressive agents ITP ❑ Corticosteroids ❑ Splenectomy ❑ Intravenous immunoglobulin ❑ Romiplostim or Etrombopag HUS ❑ Hemodialysis ❑ Corticosteroids ❑ Plasmapheresis | ||||||||||||||||||||||||||||||||||||||||||||||||||||
❑Lupus anticoagulant * LMWH * Warfairn ❑ Antiphospholipid syndrome * Aspirin(preferred in pregnancy) *Warfarin * LMWH ❑ Ehlers-Danlos syndrome * There is no known cure * Physiotherapy and Occupational therapy Vitamin C may help with bruising ❑ Leukemia * Chemotherapy ❑ Plasminogen activator inhibitor-1 deficiency * Tranexamic acid * Aminocaproic acid ❑ Alpha-2 antiplasmin deficiency * Tranexamic acid * Aminocaproic acid ❑ Factor XIII deficiency * Factor XIII concentrate ❑ Liver disease * Eltrombopag * Romiplostim * Platelet transfusions if necessary ❑ Domestic abuse must be considered in any patient with multiple bruises after ruling out other pathologies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Order a peripheral smear for all patients to rule out presence of shistocytes in conditions like TTP/HUS, DIC which need emergency treatment.
- Educate patients about red flag signs signs wherever appropriate such as epistaxis, hematemesis, melena, lethargy, pale and clammy hands and feet, oliguria or anuria.
- Early vaccination in all patients with hemophilia.
- Educate patients with bleeding disorders about wearing a medical identification tag in case of trauma or if emergency surgery is needed.
- Consider Vitamin C and Vitamin K supplementation.
- Appropriate measures to increase factor levels or platelets before any dental procedures or surgeries such as factor infusion, cryoprecipitate, fresh frozen plasma, platelet or blood transfusions.
- Regular follow up with factor levels, platelet count and response to therapy.
- Hepatitis C, Hepatitis B and HIV screening in patients who have received blood transfusions in the past.
Dont's
- Avoid contact sports.
- Avoid repeated pricks for investigations/ blood sample collection in patients with hemophilia or other bleeding disorders.
- Transfusion is contraindicated in TTP.
- Do not prescribe aspirin or other NSAIDs during phases of active bleeding.
References
- ↑ Srámek A, Eikenboom JC, Briët E, Vandenbroucke JP, Rosendaal FR (1995). "Usefulness of patient interview in bleeding disorders". Arch Intern Med. 155 (13): 1409–15. PMID 7794090.
- ↑ Wahlberg T, Blombäck M, Hall P, Axelsson G (1980). "Application of indicators, predictors and diagnostic indices in coagulation disorders. I. Evaluation of a self-administered questionnaire with binary questions". Methods Inf Med. 19 (4): 194–200. PMID 7432180.
- ↑ Mauer, A. C.; Khazanov, N. A.; Levenkova, N.; Tian, S.; Barbour, E. M.; Khalida, C.; Tobin, J. N.; Coller, B. S. (2011). "Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults". Journal of Thrombosis and Haemostasis. 9 (1): 100–108. doi:10.1111/j.1538-7836.2010.04105.x. ISSN 1538-7933.
- ↑ Schuurman R, Jacobs M, van Strien A, van der Noordaa J, Sol C (1992). "Analysis of splice sites in the early region of bovine polyomavirus: evidence for a unique pattern of large T mRNA splicing". J Gen Virol. 73 ( Pt 11): 2879–86. doi:10.1099/0022-1317-73-11-2879. PMID 1279101.
- ↑ Valente, Maria J.; Abramson, Neil (2006). "Easy Bruisability". Southern Medical Journal. 99 (4): 366–370. doi:10.1097/01.smj.0000209237.73616.33. ISSN 0038-4348.